LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy

Clinical trial NCT04562922 · COMPLETED

Trial details

NCT number: NCT04562922
Sponsor: VitalMel
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neutropenia Adverse Event

Start date: 2013-11-11
Primary completion: 2014-05-26
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.